Antero Pharma ConsultantMay 21, 20232 minMajor USFDA Regulatory Updates in April 2023On April 05, FDA issued draft guidance on “Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or...
Antero Pharma ConsultantMar 28, 20232 minExpanded Access Program - overview and notesWhat is an Expanded Access program? Expanded access or Compassionate use is the FDA program by which a doctor or registered physician can...